Biofrontera (BFRIW) Non Operating Investment Income (2022 - 2025)
Biofrontera (BFRIW) recorded quarterly Non Operating Investment Income of -$1000.0 in Q4 2025, down 200.0% quarter-over-quarter from $1000.0 in Q3 2025, and up 50.0% on a YoY basis from -$666.67 in Q4 2024.
Biofrontera (BFRIW) Non Operating Investment Income (2022 - 2025) Analysis & Trends
Biofrontera's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2025.
- In Q4 2025, Non Operating Investment Income rose 50.0% year-over-year to -$1000.0; the TTM figure through Sep 2025 stood at -$1000.0 (up 99.87% YoY), while the FY2025 annual figure was $2000.0, up 114.29% from the prior year.
- Non Operating Investment Income was -$1000.0 for Q4 2025 at Biofrontera, down from $1000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $1.7 million in Q4 2022 to a low of -$2.9 million in Q1 2023.
- Historically, Non Operating Investment Income has averaged -$473916.7 across 4 years, with a median of -$2000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Non Operating Investment Income plunged 144.99% in 2023, then soared 150.0% in 2025.
- A 4-year view of Non Operating Investment Income shows it stood at $1.7 million in 2022, then slumped by 144.99% to -$786000.0 in 2023, then soared by 99.75% to -$2000.0 in 2024, then surged by 50.0% to -$1000.0 in 2025.
- The last three Non Operating Investment Income figures came in at -$1000.0 (Q4 2025), $1000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Biofrontera | - | - | 14.09 Mn | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -786,000.00 |
| Dec 31, 2023 | -786,000.00 |
| Sep 30, 2023 | -2.21 Mn |
| Sep 30, 2023 | -2.21 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.48 Mn |